APA (7th ed.) Citation

Victoria Federico Paly, Arvind Dasari, Joleen Hubbard, Tanios Bekaii-Saab, Thihan Padukkavidana, & Luis Hernandez. (2024). Adverse event costs of systemic therapies for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatinand irinotecan-based chemotherapy and biologics in the US. Becaris Publishing Limited.

Chicago Style (17th ed.) Citation

Victoria Federico Paly, Arvind Dasari, Joleen Hubbard, Tanios Bekaii-Saab, Thihan Padukkavidana, and Luis Hernandez. Adverse Event Costs of Systemic Therapies for Metastatic Colorectal Cancer Previously Treated with Fluoropyrimidine-, Oxaliplatinand Irinotecan-based Chemotherapy and Biologics in the US. Becaris Publishing Limited, 2024.

MLA (9th ed.) Citation

Victoria Federico Paly, et al. Adverse Event Costs of Systemic Therapies for Metastatic Colorectal Cancer Previously Treated with Fluoropyrimidine-, Oxaliplatinand Irinotecan-based Chemotherapy and Biologics in the US. Becaris Publishing Limited, 2024.